M. Yokoyama

Doxorubicin-loaded poly(ethylene glycol)–poly(β-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance

Kazunori Kataoka, Tsuyoshi Matsumoto, M. Yokoyama et al. · Journal of Controlled Release · 2000 · 609 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate)

Joo Eun Chung, M. Yokoyama, Masayuki Yamato et al. · Journal of Controlled Release · 1999 · 593 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +16

Development of the polymer micelle carrier system for doxorubicin

Takeshi Nakanishi, Shigeto Fukushima, Kazuya Okamoto et al. · Journal of Controlled Release · 2001 · 566 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +12

NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel

Tsuyoshi Hamaguchi, Yasuhiro Matsumura, Masanobu Suzuki et al. · British Journal of Cancer · 2005 · 556 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood.

M. Yokoyama, Teruo Okano, Yoshinori Sakurai et al. · PubMed · 1991 · 418 citations

Pharmacy, Pharmacokinetics, Pharmacology +14